Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2015

Open Access 01-12-2015 | Research article

Inhibitory effect of Clitoria ternatea flower petal extract on fructose-induced protein glycation and oxidation-dependent damages to albumin in vitro

Authors: Poramin Chayaratanasin, Manuel Alejandro Barbieri, Nipattra Suanpairintr, Sirichai Adisakwattana

Published in: BMC Complementary Medicine and Therapies | Issue 1/2015

Login to get access

Abstract

Background

The accumulation of advanced glycation end products (AGEs) in body tissue has been implicated in the progression of age-related diseases. Inhibition of AGE formation is the imperative approach for alleviating diabetic complications. Clitoria ternatea extract (CTE) has been demonstrated to possess anti-diabetic activity. However, there is no scientific evidence supporting its anti-glycation activity. The objective of this study was to determine the inhibitory effect of CTE on fructose-induced formation of AGEs and protein oxidation. Antioxidant activity of CTE was also assessed by various methods.

Methods

The aqueous extract of CTE (0.25-1.00 mg/ml) was measured for the content of total phenolic compounds, flavonoid, and anthocyanin by Folin-Ciocalteu assay, AlCl3 colorimetric method, and pH differential method, respectively. The various concentrations of CTE were incubated with BSA and fructose at 37°C for 28 days. The formation of fluorescent AGEs, the level of fructosamine, protein carbonyl content, and thiol group were measured. The in vitro antioxidant activity was measured by the 1,1-diphenyl 2-picrylhydrazyl (DPPH) scavenging activity, trolox equivalent antioxidant capacity (TEAC), ferric reducing antioxidant power (FRAP), hydroxyl radical scavenging activity (HRSA), superoxide radical scavenging activity (SRSA), and ferrous ion chelating power (FICP).

Results

The results demonstrated that the content of total phenolics, flavonoids and total anthocyanins in CTE was 53 ± 0.34 mg gallic acid equivalents/g dried extract, 11.2 ± 0.33 mg catechin equivalents/g dried extract, and 1.46 ± 0.04 mg cyanidin-3-glucoside equivalents/g dried extract, respectively. Moreover, CTE (0.25-1.00 mg/ml) significantly inhibited the formation of AGEs in a concentration-dependent manner. CTE also markedly reduced the levels of fructosamine and the oxidation of protein by decreasing protein carbonyl content and preventing free thiol depletion. In the DPPH radical scavenging activity and SRSA, CTE had the IC50 values of 0.47 ± 0.01 mg/ml and 0.58 ± 0.04 mg/ml. Furthermore, the FRAP and TEAC values of CTE were 0.38 ± 0.01 mmol FeSO4 equivalents/mg dried extract and 0.17 ± 0.01 mg trolox equivalents/mg dried extract. However, CTE showed weak scavenging activity on hydroxyl radical and a weak antioxidant iron chelator.

Conclusions

The results showed that CTE has strong antiglycation and antioxidant properties and might have therapeutic potentials in the prevention of AGE-mediated diabetic complications.
Literature
3.
go back to reference Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia. 2001;44:129–46.CrossRefPubMed Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia. 2001;44:129–46.CrossRefPubMed
4.
go back to reference Wu CH, Huang SM, Lin JA, Yen GC. Inhibition of advanced glycation endproduct formation by foodstuffs. Food Funct. 2011;2:224–34.CrossRefPubMed Wu CH, Huang SM, Lin JA, Yen GC. Inhibition of advanced glycation endproduct formation by foodstuffs. Food Funct. 2011;2:224–34.CrossRefPubMed
5.
go back to reference Ahmed N. Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res Clin Pract. 2005;67:3–21.CrossRefPubMed Ahmed N. Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res Clin Pract. 2005;67:3–21.CrossRefPubMed
6.
go back to reference Goh SY, Cooper ME. Clinical review: the role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab. 2008;93:1143–52.CrossRefPubMed Goh SY, Cooper ME. Clinical review: the role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab. 2008;93:1143–52.CrossRefPubMed
7.
go back to reference Basta G, Schmidt AM, De Caterina R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res. 2004;63:582–92.CrossRefPubMed Basta G, Schmidt AM, De Caterina R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res. 2004;63:582–92.CrossRefPubMed
8.
go back to reference Ramasamy R, Vannucci SJ, Yan SS, Herold K, Yan SF, Schmidt AM. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology. 2005;15:16R–28.CrossRefPubMed Ramasamy R, Vannucci SJ, Yan SS, Herold K, Yan SF, Schmidt AM. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology. 2005;15:16R–28.CrossRefPubMed
9.
go back to reference Bell RC, Carlson JC, Storr KC, Herbert K, Sivak J. High-fructose feeding of streptozotocin-diabetic rats is associated with increased cataract formation and increased oxidative stress in the kidney. Br J Nutr. 2000;84:575–82.PubMed Bell RC, Carlson JC, Storr KC, Herbert K, Sivak J. High-fructose feeding of streptozotocin-diabetic rats is associated with increased cataract formation and increased oxidative stress in the kidney. Br J Nutr. 2000;84:575–82.PubMed
10.
go back to reference Tappy L, Le KA. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev. 2010;90:23–46.CrossRefPubMed Tappy L, Le KA. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev. 2010;90:23–46.CrossRefPubMed
11.
go back to reference Suárez G, Maturana J, Oronsky AL, Raventós-Suárez C. Fructose-induced fluorescence generation of reductively methylated glycated bovine serum albumin: evidence for nonenzymatic glycation of Amadori adducts. Biochim Biophys Acta. 1991;1075:12–9.CrossRefPubMed Suárez G, Maturana J, Oronsky AL, Raventós-Suárez C. Fructose-induced fluorescence generation of reductively methylated glycated bovine serum albumin: evidence for nonenzymatic glycation of Amadori adducts. Biochim Biophys Acta. 1991;1075:12–9.CrossRefPubMed
12.
go back to reference Thornalley PJ. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch Biochem Biophys. 2003;419:31–40.CrossRefPubMed Thornalley PJ. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch Biochem Biophys. 2003;419:31–40.CrossRefPubMed
14.
go back to reference Ramkissoon JS, Mahomoodally MF, Ahmed N, Subratty AH. Antioxidant and anti-glycation activities correlates with phenolic composition of tropical medicinal herbs. Asian Pac J Trop Med. 2013;6:561–9.CrossRefPubMed Ramkissoon JS, Mahomoodally MF, Ahmed N, Subratty AH. Antioxidant and anti-glycation activities correlates with phenolic composition of tropical medicinal herbs. Asian Pac J Trop Med. 2013;6:561–9.CrossRefPubMed
15.
go back to reference Kusirisin W, Srichairatanakool S, Lerttrakarnnon P, Lailerd N, Suttajit M, Jaikang C, et al. Antioxidative activity, polyphenolic content and anti-glycation effect of some Thai medicinal plants traditionally used in diabetic patients. Med Chem. 2009;5:139–47.CrossRefPubMed Kusirisin W, Srichairatanakool S, Lerttrakarnnon P, Lailerd N, Suttajit M, Jaikang C, et al. Antioxidative activity, polyphenolic content and anti-glycation effect of some Thai medicinal plants traditionally used in diabetic patients. Med Chem. 2009;5:139–47.CrossRefPubMed
16.
go back to reference Mukherjee PK, Kumar V, Kumar NS, Heinrich M. The Ayurvedic medicine Clitoria ternatea-from traditional use to scientific assessment. J Ethnopharmacol. 2008;120:291–301.CrossRefPubMed Mukherjee PK, Kumar V, Kumar NS, Heinrich M. The Ayurvedic medicine Clitoria ternatea-from traditional use to scientific assessment. J Ethnopharmacol. 2008;120:291–301.CrossRefPubMed
17.
go back to reference Gupta GK, Chahal J, Bhatia M. Clitoria ternatea (L.): old and new aspects. J Pharm Res. 2010;3:2610–4. Gupta GK, Chahal J, Bhatia M. Clitoria ternatea (L.): old and new aspects. J Pharm Res. 2010;3:2610–4.
18.
go back to reference Soundrapandian C, Datta S, Sa B. Drug-eluting implants for osteomyelitis. Crit Rev Ther Drug Carrier Syst. 2007;24:493–545.CrossRefPubMed Soundrapandian C, Datta S, Sa B. Drug-eluting implants for osteomyelitis. Crit Rev Ther Drug Carrier Syst. 2007;24:493–545.CrossRefPubMed
19.
go back to reference Adisakwattana S, Ruengsamran T, Kampa P, Sompong W. In vitro inhibitory effects of plant-based foods and their combinations on intestinal α-glucosidase and pancreatic α-amylase. BMC Complement Altern Med. 2012;12:110.CrossRefPubMedPubMedCentral Adisakwattana S, Ruengsamran T, Kampa P, Sompong W. In vitro inhibitory effects of plant-based foods and their combinations on intestinal α-glucosidase and pancreatic α-amylase. BMC Complement Altern Med. 2012;12:110.CrossRefPubMedPubMedCentral
20.
go back to reference Jariyapamornkoon N, Yibchok-anun S, Adisakwattana S. Inhibition of advanced glycation end products by red grape skin extract and its antioxidant activity. BMC Complement Altern Med. 2013;13:171.CrossRefPubMedPubMedCentral Jariyapamornkoon N, Yibchok-anun S, Adisakwattana S. Inhibition of advanced glycation end products by red grape skin extract and its antioxidant activity. BMC Complement Altern Med. 2013;13:171.CrossRefPubMedPubMedCentral
21.
go back to reference Adisakwattana S, Sompong W, Meeprom A, Ngamukote S, Yibchok-Anun S. Cinnamic acid and its derivatives inhibit fructose-mediated protein glycation. Int J Mol Sci. 2012;13:1778–89.CrossRefPubMedPubMedCentral Adisakwattana S, Sompong W, Meeprom A, Ngamukote S, Yibchok-Anun S. Cinnamic acid and its derivatives inhibit fructose-mediated protein glycation. Int J Mol Sci. 2012;13:1778–89.CrossRefPubMedPubMedCentral
22.
go back to reference Mäkynen K, Jitsaardkul S, Tachasamran P, Sakai N, Puranachoti S, Nirojsinlapachai N, et al. Cultivar variations in antioxidant and antihyperlipidemic properties of pomelo pulp (Citrus grandis [L.] Osbeck) in Thailand. Food Chem. 2013;139:735–43.CrossRefPubMed Mäkynen K, Jitsaardkul S, Tachasamran P, Sakai N, Puranachoti S, Nirojsinlapachai N, et al. Cultivar variations in antioxidant and antihyperlipidemic properties of pomelo pulp (Citrus grandis [L.] Osbeck) in Thailand. Food Chem. 2013;139:735–43.CrossRefPubMed
23.
go back to reference Wautier J, Guillausseau P. Advanced glycation end products, their receptors and diabetic angiopathy. Diabetes Metab. 2001;27:535–42.PubMed Wautier J, Guillausseau P. Advanced glycation end products, their receptors and diabetic angiopathy. Diabetes Metab. 2001;27:535–42.PubMed
25.
go back to reference Dearlove RP, Greenspan P, Hartle DK, Swanson RB, Hargrove JL. Inhibition of protein glycation by extracts of culinary herbs and spices. J Med Food. 2008;11:275–81.CrossRefPubMed Dearlove RP, Greenspan P, Hartle DK, Swanson RB, Hargrove JL. Inhibition of protein glycation by extracts of culinary herbs and spices. J Med Food. 2008;11:275–81.CrossRefPubMed
26.
go back to reference Caengprasath N, Ngamukote S, Mäkynen K, Adisakwattana S. The protective effects of pomelo extract (Citrus Grandis L. Osbeck) against fructose-mediated protein oxidation and glycation. EXCLI J. 2013;12:491–502.PubMedPubMedCentral Caengprasath N, Ngamukote S, Mäkynen K, Adisakwattana S. The protective effects of pomelo extract (Citrus Grandis L. Osbeck) against fructose-mediated protein oxidation and glycation. EXCLI J. 2013;12:491–502.PubMedPubMedCentral
27.
go back to reference Adisakwattana S, Jiphimai P, Prutanopajai P, Chanathong B, Sapwarobol S, Ariyapitipan T. Evaluation of alpha-glucosidase, alpha-amylase and protein glycation inhibitory activities of edible plants. Int J Food Sci Nutr. 2010;61:295–305.CrossRefPubMed Adisakwattana S, Jiphimai P, Prutanopajai P, Chanathong B, Sapwarobol S, Ariyapitipan T. Evaluation of alpha-glucosidase, alpha-amylase and protein glycation inhibitory activities of edible plants. Int J Food Sci Nutr. 2010;61:295–305.CrossRefPubMed
28.
go back to reference Adisakwattana S, Thilavech T, Chusak C. Mesona Chinensis Benth extract prevents AGE formation and protein oxidation against fructose-induced protein glycation in vitro. BMC Complement Altern Med. 2014;14:130.CrossRefPubMedPubMedCentral Adisakwattana S, Thilavech T, Chusak C. Mesona Chinensis Benth extract prevents AGE formation and protein oxidation against fructose-induced protein glycation in vitro. BMC Complement Altern Med. 2014;14:130.CrossRefPubMedPubMedCentral
29.
go back to reference Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. FEBS Lett. 2008;582:1783–7.CrossRefPubMed Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. FEBS Lett. 2008;582:1783–7.CrossRefPubMed
30.
go back to reference Chesne S, Rondeau P, Armenta S, Bourdon E. Effects of oxidative modifications induced by the glycation of bovine serum albumin on its structure and on cultured adipose cells. Biochimie. 2006;88:1467–77.CrossRefPubMed Chesne S, Rondeau P, Armenta S, Bourdon E. Effects of oxidative modifications induced by the glycation of bovine serum albumin on its structure and on cultured adipose cells. Biochimie. 2006;88:1467–77.CrossRefPubMed
31.
go back to reference Smith PR, Thornalley PJ. Mechanism of the degradation of non‐enzymatically glycated proteins under physiological conditions. Eur J Biochem. 1992;210:729–39.CrossRefPubMed Smith PR, Thornalley PJ. Mechanism of the degradation of non‐enzymatically glycated proteins under physiological conditions. Eur J Biochem. 1992;210:729–39.CrossRefPubMed
32.
go back to reference Kang JH. Oxidative damage of DNA induced by methylglyoxal in vitro. Toxicol Lett. 2003;145:181–7.CrossRefPubMed Kang JH. Oxidative damage of DNA induced by methylglyoxal in vitro. Toxicol Lett. 2003;145:181–7.CrossRefPubMed
33.
go back to reference Szaleczky E, Prechl J, Fehér J, Somogyi A. Alterations in enzymatic antioxidant defence in diabetes mellitus-a rational approach. Postgrad Med J. 1999;75:13–7.CrossRefPubMedPubMedCentral Szaleczky E, Prechl J, Fehér J, Somogyi A. Alterations in enzymatic antioxidant defence in diabetes mellitus-a rational approach. Postgrad Med J. 1999;75:13–7.CrossRefPubMedPubMedCentral
34.
go back to reference Rice-Evans C, Miller N, Paganga G. Antioxidant properties of phenolic compounds. Trends Plant Sci. 1997;2:152–9.CrossRef Rice-Evans C, Miller N, Paganga G. Antioxidant properties of phenolic compounds. Trends Plant Sci. 1997;2:152–9.CrossRef
36.
go back to reference Einbond LS, Reynertson KA, Luo X-D, Basile MJ, Kennelly EJ. Anthocyanin antioxidants from edible fruits. Food Chem. 2004;84:23–8.CrossRef Einbond LS, Reynertson KA, Luo X-D, Basile MJ, Kennelly EJ. Anthocyanin antioxidants from edible fruits. Food Chem. 2004;84:23–8.CrossRef
37.
go back to reference Terahara N, Oda M, Matsui T, Osajima Y, Saito N, Toki K, et al. Five new anthocyanins, ternatins A3, B4, B3, B2, and D2, from Clitoria ternatea flowers. J Nat Prod. 1996;59:139–44.CrossRefPubMed Terahara N, Oda M, Matsui T, Osajima Y, Saito N, Toki K, et al. Five new anthocyanins, ternatins A3, B4, B3, B2, and D2, from Clitoria ternatea flowers. J Nat Prod. 1996;59:139–44.CrossRefPubMed
38.
go back to reference Ho SC, Wu SP, Lin SM, Tang YL. Comparison of anti-glycation capacities of several herbal infusions with that of green tea. Food Chem. 2010;122:768–74.CrossRef Ho SC, Wu SP, Lin SM, Tang YL. Comparison of anti-glycation capacities of several herbal infusions with that of green tea. Food Chem. 2010;122:768–74.CrossRef
Metadata
Title
Inhibitory effect of Clitoria ternatea flower petal extract on fructose-induced protein glycation and oxidation-dependent damages to albumin in vitro
Authors
Poramin Chayaratanasin
Manuel Alejandro Barbieri
Nipattra Suanpairintr
Sirichai Adisakwattana
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2015
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-015-0546-2

Other articles of this Issue 1/2015

BMC Complementary Medicine and Therapies 1/2015 Go to the issue